新型假针刺方法用于双盲试验的验证研究
真针刺取合谷与足三里,假针刺模拟真针刺但不刺入皮肤。结果显示足三里处受试者盲法成功,合谷处盲法有局限;真针刺组穿透感和疼痛更高,两组均无不良事件。
要点
- 新假针刺在足三里穴对受试者盲法成功,合谷穴盲法效果有限。
- 真针刺组穿透感和疼痛评分高于假针刺组,得气感反应不一。
- 两组均未报告不良事件,提示该方法安全性可接受。
核心结论
- 新开发的假针刺在足三里穴对受试者和操作者盲法有潜力,但在合谷穴盲法效果存在局限。
主要发现
- 受试者盲法在足三里穴成功维持,合谷穴假针刺组出现多于随机预期的正确猜测。
- 操作者对两穴所施真/假针刺的猜测呈随机分布。
- 真针刺组两穴的穿透感和疼痛均高于假针刺组,得气感反应不一。
- 真针刺组和假针刺组均无不良事件。
关键数值与推荐
- 盲法评价采用Bang盲法指数,穿透感、疼痛和得气感采用标准化问卷和11点数字评分量表评估。
- 真针刺取合谷(LI4)和足三里(ST36),假针刺模拟真针刺但不刺入皮肤。
临床怎么用
- 在足三里穴进行双盲针刺试验时可考虑使用该假针刺方法,合谷穴需谨慎评估盲法效果。
- 临床研究设计时应结合穴位选择验证假针刺的盲法成功率。
局限性
- 仅在合谷和足三里两个穴位验证,其他穴位效果未知。
- 受试者为健康人群,未在特定患者群体中验证。
- 合谷穴盲法效果有限,提示该方法存在穴位依赖性局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Various clinical studies have been conducted worldwide to evaluate the effectiveness of acupuncture; however, designing an adequate control group is challenging. Sham acupuncture tools, designed to mimic real acupuncture without skin penetration, aim to address this challenge, but their efficacy and blinding success are debated. METHODS: In this study, we conducted a randomized, double-blind, parallel-group clinical trial to validate a newly developed sham acupuncture method for future double-blind trials. Sixty-six healthy participants were randomly assigned to verum or sham acupuncture groups. Verum acupuncture targeted LI4 and ST36, common acupuncture points, while sham acupuncture aimed to mimic verum without skin penetration to ensure participant blinding. Blinding (Bang's Blinding Index), penetration, pain, and deqi sensations were evaluated using a standardized questionnaire and an 11-point Numeric Rating Scale. RESULTS: Participant blinding was successfully maintained at ST36, whereas "more correct guesses" were observed for verum acupuncture than expected by chance for sham acupuncture at LI4. Furthermore, the practitioners randomly guessed the verum and sham acupuncture that they had administered to both points. Penetration and pain were higher in the verum group for both points, while deqi sensations had mixed responses. There were no adverse events in the verum acupuncture and sham acupuncture groups. CONCLUSIONS: The newly developed sham acupuncture demonstrated potential in blinding participants and practitioners, particularly at ST36. However, challenges were observed, especially at LI4, indicating limitations in blinding efficacy. This study underscores the importance of additional validation studies with larger sample sizes, diverse acupuncture points, and specific patient populations. TRIAL REGISTRATION: Clinical Research Information Service of the Republic of Korea (registration number: KCT0008335, https://cris.nih.go.kr).
引用
- Lim SM, Go E, Lee J, et al. Introducing a novel sham acupuncture method for double-blind trials: A validation study. Complement Ther Med. 2025. PMID: 40619110. doi:10.1016/j.ctim.2025.103198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。